United Capital Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,340
| Closed | -$231K | – | 1104 |
|
2024
Q3 | $231K | Sell |
2,340
-133
| -5% | -$13.1K | ﹤0.01% | 957 |
|
2024
Q2 | $229K | Buy |
2,473
+60
| +2% | +$5.56K | ﹤0.01% | 933 |
|
2024
Q1 | $229K | Buy |
2,413
+45
| +2% | +$4.27K | ﹤0.01% | 967 |
|
2023
Q4 | $211K | Sell |
2,368
-1,462
| -38% | -$131K | ﹤0.01% | 986 |
|
2023
Q3 | $280K | Sell |
3,830
-734
| -16% | -$53.6K | ﹤0.01% | 741 |
|
2023
Q2 | $380K | Sell |
4,564
-10,621
| -70% | -$884K | ﹤0.01% | 725 |
|
2023
Q1 | $1.16M | Buy |
15,185
+538
| +4% | +$41K | 0.01% | 542 |
|
2022
Q4 | $1.22M | Sell |
14,647
-1,420
| -9% | -$118K | 0.01% | 572 |
|
2022
Q3 | $1.27M | Sell |
16,067
-460
| -3% | -$36.5K | 0.01% | 562 |
|
2022
Q2 | $1.23M | Buy |
16,527
+144
| +0.9% | +$10.7K | 0.01% | 592 |
|
2022
Q1 | $1.47M | Buy |
16,383
+5,301
| +48% | +$476K | 0.01% | 587 |
|
2021
Q4 | $1.24M | Buy |
11,082
+237
| +2% | +$26.5K | 0.01% | 633 |
|
2021
Q3 | $1.36M | Sell |
10,845
-4
| -0% | -$503 | 0.01% | 601 |
|
2021
Q2 | $1.47M | Buy |
10,849
+140
| +1% | +$19K | 0.01% | 602 |
|
2021
Q1 | $1.45M | Buy |
10,709
+103
| +1% | +$14K | 0.01% | 575 |
|
2020
Q4 | $1.49M | Buy |
10,606
+608
| +6% | +$85.6K | 0.01% | 572 |
|
2020
Q3 | $1.11M | Buy |
9,998
+549
| +6% | +$61.2K | 0.01% | 630 |
|
2020
Q2 | $1.06M | Buy |
9,449
+296
| +3% | +$33.1K | 0.01% | 645 |
|
2020
Q1 | $709K | Buy |
9,153
+856
| +10% | +$66.3K | 0.01% | 705 |
|
2019
Q4 | $789K | Buy |
8,297
+353
| +4% | +$33.6K | 0.01% | 854 |
|
2019
Q3 | $606K | Buy |
7,944
+4,541
| +133% | +$346K | ﹤0.01% | 884 |
|
2019
Q2 | $299K | Sell |
3,403
-117
| -3% | -$10.3K | ﹤0.01% | 1197 |
|
2019
Q1 | $319K | Buy |
3,520
+335
| +11% | +$30.4K | ﹤0.01% | 1089 |
|
2018
Q4 | $229K | Sell |
3,185
-349
| -10% | -$25.1K | ﹤0.01% | 1158 |
|
2018
Q3 | $339K | Buy |
3,534
+802
| +29% | +$76.9K | ﹤0.01% | 1064 |
|
2018
Q2 | $260K | Buy |
2,732
+416
| +18% | +$39.6K | ﹤0.01% | 1140 |
|
2018
Q1 | $203K | Buy |
+2,316
| New | +$203K | ﹤0.01% | 1232 |
|
2017
Q4 | – | Sell |
-2,306
| Closed | -$200K | – | 1364 |
|
2017
Q3 | $200K | Buy |
+2,306
| New | +$200K | ﹤0.01% | 1237 |
|
2016
Q1 | – | Sell |
-5,858
| Closed | -$411K | – | 1285 |
|
2015
Q4 | $411K | Sell |
5,858
-5,373
| -48% | -$377K | ﹤0.01% | 934 |
|
2015
Q3 | $699K | Sell |
11,231
-101,395
| -90% | -$6.31M | 0.01% | 798 |
|
2015
Q2 | $9.47M | Buy |
112,626
+98,310
| +687% | +$8.27M | 0.11% | 226 |
|
2015
Q1 | $985K | Buy |
+14,316
| New | +$985K | 0.01% | 723 |
|